IRVING, Texas, August 10, 2016 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Annual Meeting of the American College of Gastroenterology (ACG), which will be held October 14–19 in Las Vegas.
Authors from Miraca Life Sciences are linked below to their profile on the company website.
One study has received the 2016 ACG Presidential Poster Award, given by the ACG Educational Affairs Committee to the most highly ranked abstract in each submission category:
- “Duodenal Intraepithelial Lymphocytosis: A Condition with a Distinct Seasonal Incidence,” authors Robert M. Genta, Amnon Sonnenberg, Kevin Turner.
Two posters demonstrate the high clinical value of the company’s EoGenius RNA expression test for eosinophilic esophagitis:
- “A Gene Expression Profile Test [EoGenius] Can Predict Subsequent Development of Histologic Eosinophilic Esophagitis in Patients with Non-diagnostic Index Biopsies,” authors Richard Lash, Ranjitha Veerappan, Robert M. Genta, Kimberly Schwanbeck.
- “A Gene Expression Profile Test [EoGenius] for the Diagnosis of Eosinophilic Esophagitis Shows Excellent Correlation with Histological Findings of Esophageal Biopsies,” authors Danilo V. Tadeo, Jr., Bisher Abdullah, Jennifer Scudiere, Richard Lash, Robert M. Genta.
Seven additional studies from Miraca researchers will be presented at ACG:
- “Eosinophilic Esophagitis: Male Predominance Is Present Across All Ethnic Groups,” Robert M. Genta, Kevin Turner.
- “Duodenal Intraepithelial Lymphocytosis Is a Predictor of Villous Atrophy in Follow-up Biopsies,” authors Richard Lash, Robert M. Genta, Kevin Turner.
- “Colorectal Polyps: Lesions of All Types Exist in Polyps of All Sizes,” authors Kevin Turner, Robert M. Genta, Richard Lash, Amnon Sonnenberg.
- “Incidental Goblet Cells at the Gastroesophageal Junction: Intestinal Metaplasia of the Esophagus or Stomach?” authors Kevin Turner, Stuart J. Spechler, Amnon Sonnenberg, Robert M. Genta.
- “Sampling from Both Duodenal Bulb and Jejunum Is the Most Valuable Combination for the Biopsy Diagnosis of Celiac Disease,” authors Guy Lindberg, Kevin Turner, Robert M. Genta.
- “Lymphocytic Gastritis: Three Distinct Conditions Defined by Topography,” authors Jonathan G. Lash, Kevin Turner, Robert M. Genta.
- “Esophageal and Gastric Disease in U.S. Residents with Ancestry in Different Regions of India,” authors Robert Genta, Reenu Malhotra, Kevin Turner.
About Miraca Life Sciences
Miraca Life Sciences provides proven high-quality anatomic pathology services, focusing on the fields of dermatology, hematology, gastroenterology, urology, and breast health. The company’s team of nearly 90 distinguished subspecialist pathologists utilizes state-of-the-art laboratories to serve more than 5,500 patients every day. Miraca Life Sciences’ difference is based on consensus-based medicine (including comprehensive sub-subspecialization, unified terminology and criteria, daily consensus conferences, extensive educational activities), rigorous quality assurance, active clinical research, innovation in testing, technological advancements, and health IT consulting services for clinician clients. Headquartered in Irving, Texas, Miraca Life Sciences is a subsidiary of Miraca Holdings Inc., one of Japan’s largest clinical diagnostics and laboratory testing service providers. For more information, visit www.MiracaLifeSciences.com.
# # #
Media contact information:
Joy Jennings, Director of Marketing